NewAmsterdam Pharma Company NV
$20.04
6
+$1.63+8.85% Tuesday 18:37
Statistics
Day High
20.07
Day Low
20.04
52W High
29.99
52W Low
5.45
Volume
545
Avg. Volume
768
Mkt Cap
2.29B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.485081
Actual EPS
N/A
Financials
-905.74%Profit Margin
Unprofitable45.01MRevenue
-407.64MNet Income
Analyst Ratings
$47.00Average Price Target
The highest estimate is 52.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 86%
Hold 14%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NAMSW. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novo Nordisk
NVO
Mkt Cap217.54B
Merck
MRK
Mkt Cap214.76B
Pfizer
PFE
Mkt Cap140.15B
Astrazeneca
AZN
Mkt Cap256.58B
Sanofi
SNY
Mkt Cap124.45B
Lilly(Eli) &
LLY
Mkt Cap772.28B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
GSK
GSK
Mkt Cap94.51B
About
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
Show more...
CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Employees
68
Country
NL
ISIN
NL00150012K9
Listings
0 Comments
Share your thoughts
FAQ
What is NewAmsterdam Pharma Company NV stock price today?▼
The current price of NAMSW is $20.04 USD — it has increased by +8.85% in the past 24 hours. Watch NewAmsterdam Pharma Company NV stock price performance more closely on the chart.
What is NewAmsterdam Pharma Company NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NewAmsterdam Pharma Company NV stocks are traded under the ticker NAMSW.
Is NewAmsterdam Pharma Company NV stock price growing?▼
NAMSW stock has fallen by -4.39% compared to the previous week, the month change is a -19.84% fall, over the last year NewAmsterdam Pharma Company NV has showed a +180.67% increase.
What is NewAmsterdam Pharma Company NV market cap?▼
Today NewAmsterdam Pharma Company NV has the market capitalization of 2.29B
When is the next NewAmsterdam Pharma Company NV earnings date?▼
NewAmsterdam Pharma Company NV is going to release the next earnings report on May 07, 2026.
What were NewAmsterdam Pharma Company NV earnings last quarter?▼
NAMSW earnings for the last quarter are -0.62 USD per share, whereas the estimation was -0.56 USD resulting in a -11.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NewAmsterdam Pharma Company NV revenue for the last year?▼
NewAmsterdam Pharma Company NV revenue for the last year amounts to 45.01M USD.
What is NewAmsterdam Pharma Company NV net income for the last year?▼
NAMSW net income for the last year is -407.64M USD.
How many employees does NewAmsterdam Pharma Company NV have?▼
As of April 01, 2026, the company has 68 employees.
In which sector is NewAmsterdam Pharma Company NV located?▼
NewAmsterdam Pharma Company NV operates in the Health Care sector.
When did NewAmsterdam Pharma Company NV complete a stock split?▼
NewAmsterdam Pharma Company NV has not had any recent stock splits.
Where is NewAmsterdam Pharma Company NV headquartered?▼
NewAmsterdam Pharma Company NV is headquartered in Naarden, NL.